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Regulatory T (Treg) cells are a developmentally and functionally distinct T cell subpopulation that is engaged
in sustaining immunological self-tolerance and homeostasis. The transcription factor Foxp3 plays a key role
in Treg cell development and function. However, expression of Foxp3 alone is not sufficient for conferring and
maintaining Treg cell function and phenotype. Complementing the insufficiency, Treg-cell-specific epige-
netic changes are also critical in the process of Treg cell specification, in regulating its potential plasticity,
and hence in establishing a stable lineage. Understanding how epigenetic alterations and Foxp3 expression
coordinately control Treg-cell-specific gene regulation will enable better control of immune responses by tar-
geting the generation and maintenance of Treg cells.Introduction
Naturally occurring CD25+CD4+ regulatory T (Treg) cells, which
constitutively express the transcription factor Foxp3, are indis-
pensable for the maintenance of immune self-tolerance and
homeostasis by suppressing aberrant or excessive immune
responses harmful to the host (Rudensky, 2011; Sakaguchi
et al., 2008). The majority of Foxp3+ natural Treg (nTreg) cells
are produced by the thymus as an antigen-primed and function-
ally mature T cell subpopulation specialized for immune
suppression. Some of them also differentiate from naı¨ve conven-
tional T (Tconv) cells in the periphery under certain conditions.
Themain task of Foxp3+ nTreg cells is to migrate to inflammation
sites and suppress various effector lymphocytes, especially
helper T (Th) cell subsets: Th1, Th2, Th17, and follicular Th
(Tfh) cells (Chaudhry et al., 2009; Chung et al., 2011; Koch
et al., 2009; Linterman et al., 2011). These features of nTreg cells
raise the issues of how their cell fate as a distinct cell lineage is
determined in the thymus; how their functional and phenotypic
stability is maintained in the periphery with certain adaptability
to inflammatory environments; and how peripherally induced
Treg (iTreg) cells are different from thymus-produced ones in
the mode of their generation, cell fate, and functional stability.
These issues are also relevant in clinical settings to enrich and
expand functionally stable Treg cells for immune suppression
or to specifically deplete Treg cells or attenuate their suppressive
activity for enhancing immune responses.
There is substantial evidence that Foxp3, a forkhead tran-
scription factor encoded by the X chromosome, plays a critical
role in the development and function of Treg cells (Fontenot
et al., 2003; Hori et al., 2003). Mutations of human FOXP3 result
in impaired development or dysfunction of Treg cells and,
consequently, the occurrence of immunodysregulation polyen-
docrinopathy enteropathy X-linked syndrome accompanying
severe autoimmune diseases, inflammatory bowel disease,
and allergy (Bennett et al., 2001). Likewise, mice that carry
a mutation or genetic deletion of Foxp3 are deficient in Treg
cells and develop fatal systemic autoimmunity (Brunkow
et al., 2001; Fontenot et al., 2003). In addition, forced expres-
sion of Foxp3 is able to confer Treg-cell-like suppressive414 Immunity 38, March 21, 2013 ª2013 Elsevier Inc.activity on Tconv cells (Fontenot et al., 2003; Hori et al.,
2003). Foxp3 has therefore been considered as a lineage-spec-
ifying transcription factor of Treg cells or a master regulator of
its functions.
There are, however, several indications that Foxp3 expression
per se might not be sufficient for stably maintaining Treg cell
suppressive function or reliably delineating functional Treg cells.
For example, activated human Tconv cells transiently express
FOXP3 at a low level without acquiring Treg cell suppressive
activity (Allan et al., 2007). CD4+ T cells in human peripheral
blood contain a FOXP3+ T cell subpopulation that does not
exhibit Treg cell suppressive activity and even produces proin-
flammatory cytokines upon activation (Miyara et al., 2009). Anal-
ysis of Foxp3gfp mice, in which Foxp3 is disrupted by the inser-
tion of the gene encoding GFP, demonstrated that
Foxp3GFP+ T cells express some Treg cell signature genes,
such as Ctla4 and Il2ra (Gavin et al., 2007; Lin et al., 2007).
Thus, not all of the Foxp3+ T cells are functional Treg cells, and
Treg cell signature molecules can be expressed, at least to
a certain extent, without Foxp3. Consistently, ectopic retroviral
transduction of Foxp3 in Tconv cells has failed to induce the
expression of many Treg cell signature genes (Hill et al., 2007;
Sugimoto et al., 2006). In addition, Treg cell clones or lines main-
tained in vitro are functionally stable (Levings et al., 2001). Also,
an in vivo cell-fate-chasing study has shown that Foxp3+ nTreg
cells represent a stable cell lineage that is capable of sustaining
Foxp3 expression and suppressive function overmultiple rounds
of cell division, even in inflammatory environments (Rubtsov
et al., 2010). Taken together, these findings suggest that Treg
cell development is not quite as simple as the widely accepted
Foxp3-centered scheme that Foxp3 expression is sufficient to
define nTreg cells or to determine their cell fate and function.
An additional molecular event (or events) might complement
Foxp3 function in the generation of Treg cells and the mainte-
nance of their function and phenotype.
In this review, we discuss the molecular basis of Treg cell
development and function by focusing on how epigenetic regu-
lation and Foxp3 expression independently and coordinately
control Treg cell development and function.
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Epigenetic modifications, which include histone modifications,
DNA methylation, microRNAs, nucleosome positioning, chro-
matin interaction, and chromosome conformational changes,
play indispensable roles in cell differentiation, especially for
cell-lineage stabilization (Gibney and Nolan, 2010; Kim et al.,
2009; Musri and Pa´rrizas, 2012). In particular, DNA methylation
and histone modifications critically contribute to cell-lineage
determination and maintenance because they are heritable
through cell divisions. Genomic DNA is mainly methylated by
DNA methyltransferases (Dnmt family members), whereas it
can be demethylated bymultiple steps, includingmethylcytosine
hydroxylation mediated by TET family members (Bhutani et al.,
2011; Pastor et al., 2011). Similarly, histones are modified for
gene activation or repression by acetylation or deacetylation,
methylation or demethylation, and phosphorylation or dephos-
phorylation (Teperino et al., 2010). Thus, epigenetic status is
reversible. It is also known, however, that DNA methylation
status modified in the early stages of development, such as
genomic imprinting, is stably maintained throughout subsequent
differentiation processes. Epigenetic changes of some specific
loci are also stably sustained in specific cell lineages, including
Treg cells (Ansel et al., 2003; Ohkura et al., 2012; Schmidl
et al., 2009; Thomas et al., 2012).
Recent genome-wide analyses have revealed several regions
that show different patterns of DNAmethylation or histone modi-
fication between Tconv and Treg cells in humans and mice
(Floess et al., 2007; Ohkura et al., 2012; Schmidl et al., 2009;
Wei et al., 2009). For example, Treg-cell-specific DNA hypome-
thylation occurs in a limited number of loci, half of which are
located in small regions within gene bodies (exons and introns).
Such genes with Treg-cell-specific DNA hypomethylation
include those encoding Treg-cell-function-associated or Treg-
cell-specific molecules, such as Foxp3, CTLA-4, and Eos
(Ohkura et al., 2012). Many of the differentially methylated
regions harbor DNA-methylation-dependent enhancer activity
in reporter-gene assays (Schmidl et al., 2009). Furthermore,
some of the Treg-cell-specific changes in DNA methylation are
highly stable in Treg cells, whereas others are not. For example,
Foxp3 intron 1 (corresponding to Foxp3 conserved noncoding
sequence 2 [CNS2]), Ctla4 exon 2, and Ikzf4 (encoding Eos)
intron 1, are specifically demethylated in nTreg cells, and the hy-
pomethylation is stable after T cell receptor (TCR) stimulation,
cell proliferation, or cytokine treatments (e.g., with IL-2 or
TGF-b) (Ohkura et al., 2012). In contrast, the DNA methylation
status of Il2ra intron 1, which is demethylated in nonactivated
Treg cells, is relatively unstable and becomes demethylated in
Tconv cells by mere in vitro culture with or without TCR stimula-
tion. In addition, enhanced H3K4me3 histone modification of the
Treg cell signature genes detected in nTreg cells is easily primed
in Tconv cells under a Th1-, Th2-, or Th17-cell-polarizing or
iTreg-cell-inducing condition (Wei et al., 2009) (Figure 1). In line
with these findings, a high-resolution DNaseI footprint analysis
has shown that specific alterations in chromatin accessibility
occur in Treg cells in the course of their differentiation from their
precursors (Samstein et al., 2012). Although the DNaseI-hyper-
sensitive regions do not differ mostly between CD4+Foxp3
T cells and CD4+Foxp3+ T cells, a small number of genes show
increased hypersensitivity in Treg cells, indicating specific alter-ations in local nucleosome positioning and chromatin accessi-
bility. The loci identified as newly accessible in Treg cells are en-
riched in the genes known to be critical for Treg cell function,
such as Foxp3,Ctla4 and Ikzf2. They are also classified as genes
possessing Treg-cell-specific DNA hypomethylated regions in
Treg cells, as discussed above (Ohkura et al., 2012; Schmidl
et al., 2009). Thus, Treg cells acquire and sustain highly specific
and stable epigenetic changes as exemplified by DNA hypome-
thylation at specific loci of a limited number of genes. This
Treg-cell-specific DNA hypomethylation is a reliable marker for
assessing the epigenetic status of Treg cells.
The Molecular Basis of Treg-Cell-Specific DNA
Hypomethylation
DNA hypomethylation is generally associated with an open chro-
matin structure, and one of the molecular consequences is
increased accessibility of transcription factors to particular
genomic regions for the enhancement of transcription. A lucif-
erase reporter assay incorporating the methylated or demethy-
lated Foxp3 CNS2 region has indeed shown that its demethyla-
tion substantially increases the gene transcription in Treg and
non-Treg cells, indicating that demethylation promotes gene
expression by utilizing molecules commonly present in Treg
and non-Treg cells (Polansky et al., 2010) (Figure 2). Methylated
DNA is known to be bound by factors such as DNA-methyl-
binding-domain proteins, methyl CpG-binding proteins, Kaiso,
and some ZBTB proteins, and these factors assist the repression
of target-gene transcription by preventing the binding of tran-
scription factors and recruiting HDAC and histone methyltrans-
ferases (Tost, 2010). Although the order of molecular events
involving histone modification, DNA methylation, and chromatin
remodeling is a subject of much debate, demethylation of DNA is
suggested to interfere with the action of these transcriptional
repressors and instead allow the binding of other factors. In
fact, Ets-1 specifically binds to the demethylated CNS2 region
of Foxp3 (Polansky et al., 2010). This region is also bound by
Foxp3, Gata-3, and STAT5 in Treg cells, either directly or indi-
rectly, and targeted deletion of the Foxp3 CNS2 region or
Gata3 in Treg cells results in reduced transcription activity of
Foxp3 (Rudra et al., 2012; Yao et al., 2007; Zheng et al., 2010).
Collectively, DNA demethylation of the CNS2 region allows
enhanced gene expression at the Foxp3 locus. It needs to be
examined whether other gene loci specifically demethylated in
Treg cells exhibit similar enhancing effects.
Roles of Epigenetic Changes and Foxp3 Expression
in Treg Cells
With the presence of the Treg-cell-specific DNA hypomethyla-
tion pattern in nTreg cells, it can be asked when it is installed
in Treg cells, how it contributes to Treg-cell-type gene expres-
sion, and how its contribution is distinct from that of Foxp3. In
the thymus, the Treg-cell-specific epigenetic pattern becomes
evident in developing Treg cells or their precursors at the CD4-
single-positive stage; it progresses from the thymus to
the periphery to become firmly established (Ohkura et al.,
2012). Importantly, in Foxp3-null mice that express GFP from
the Foxp3 promoter but fail to express Foxp3, GFP+CD4+CD8
thymocytes acquire the Treg-cell-type DNA hypomethylation
pattern to an extent and with a time course similar to those ofImmunity 38, March 21, 2013 ª2013 Elsevier Inc. 415
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Figure 1. Epigenetic Status of Foxp3
A schematic representation of Foxp3 shows the reference sequence (RefSeq) of the gene locus, DNaseI-hypersensitive regions determined by DNaseI
sequencing (DNaseI) (Samstein et al., 2012), methylated DNA regions by methylated DNA immunoprecipitation sequencing (MeDIP) (Ohkura et al., 2012),
H3K4me3 modification by chromatin immunoprecipitation (ChIP) sequencing (H3K4me3) (Wei et al., 2009), ChIP sequencing against transcription factors
(Samstein et al., 2012; Zheng et al., 2007), and RNA expression by RNA sequencing (RNA) (unpublished data). Red rectangles indicate Foxp3 CNS1 and CNS2
regions. ‘‘Act. naı¨ve1’’ and ‘‘act. naı¨ve2’’ represent naı¨ve T cells stimulated with CD3 and CD28 antibodies (naı¨ve1) and with PMA and ionomycin (naı¨ve2).
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whole-gene expression pattern is also similar between nTreg
cells and those installed with the Treg-cell-specific epigenetic
pattern but not expressing Foxp3. These findings collectively
indicate that Treg-cell-type DNA hypomethylation is installed in
developing Treg cells without Foxp3 expression and contribute
to the whole-gene expression profiles in steady-state Treg cells.
Treg-cell-specific DNA hypomethylation and Foxp3 expres-
sion have distinct roles in establishing Treg-cell-type gene416 Immunity 38, March 21, 2013 ª2013 Elsevier Inc.expression. Foxp3 represses expression of some key molecules
for Treg cell function, such as IL-2, IFN-g and Zap70, whereas
Treg-cell-specific epigenetic changes do not (Ohkura et al.,
2012). Treg-cell-specific DNA-hypomethylation-dependent
gene regulations, e.g., enhancement of Ikzf2 and Ikzf4 expres-
sion, are independent of Foxp3. Supporting this possible division
of labor, Treg-cell-specific DNA hypomethylated regions in the
genome are mostly different from Foxp3-binding sites (Ohkura
et al., 2012; Samstein et al., 2012; Zheng et al., 2007). Moreover,
Figure 2. Functional Significance of Treg-Cell-Type Epigenetic Changes
In nTreg cells, specific DNA hypomethylation was observed in the Foxp3 CNS2 region, in which several transcription factors (including Ets1, CREB, and Foxp3
itself) assemble and activate Foxp3 expression, irrespective of the extracellular stimulations, such as TGF-b. In contrast, for in vitro iTreg cells induced by TGF-b,
DNA hypomethylation does not occur in either the CNS1 or the CNS2 region, whereas H3K4me3 modification is enhanced in the CNS1 region, in which Smad3
locates and activates Foxp3 expression. After removal of TGF-b, Foxp3 expression is not maintained in these iTreg cells.
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between Treg and Tconv cells (Samstein et al., 2012), suggesting
that Foxp3-dependent gene regulation is independent of Treg-
cell-specific epigenetic changes. Notably, however, both
Foxp3 expression and Treg-cell-type DNA hypomethylation are
involved in controlling the expression of some Treg-cell-func-
tion-associated molecules, such as Il2ra,Ctla4, and Foxp3 itself,
especially upon TCR stimulation (Hill et al., 2007; Hori et al.,
2003; Ono et al., 2007). Taken together, it is likely that Foxp3-
dependent gene regulation and Treg-cell-epigenome-depen-
dent regulation have distinct roles in determining the whole
Treg-cell-type gene expression pattern and complement mutu-
ally in the expression of certain specific genes in Treg cells.
What, then, induces Foxp3 and the Treg cell epigenome in
developing Treg cells in the thymus and the periphery? TCRstimulation is an important factor for both events (Jordan et al.,
2001; Kawahata et al., 2002; Ohkura et al., 2012), yet it seems
that the quality of TCR stimulation required for Foxp3 induction
or Treg-cell-epigenome installation is different. Foxp3 expres-
sion in developing thymocytes appears to depend chiefly on
the intensity of TCR stimulation (Jordan et al., 2001; Kawahata
et al., 2002) and is rapidly induced after TCR stimulation
(Figure 3). In contrast, the acquisition of Treg-cell-specific DNA
hypomethylation appears to depend on the duration of TCR
stimulation (Ohkura et al., 2012). It is thus likely in thymic Treg
cell development that only those thymocytes that have acquired
Treg-cell-type epigenetic changes with TCR stimulation become
poised for expressing Foxp3 and consequently express Foxp3
by receiving an appropriate strength of TCR stimulation and
thereby develop into stable Foxp3+ Treg cells. This indicatesImmunity 38, March 21, 2013 ª2013 Elsevier Inc. 417
Figure 3. A Model for Treg Cell
Development in the Thymus
In developing T cells in the thymus, TCR gene re-
arrangement generates diverse TCRs that recog-
nize self-ligands at various intensities and dura-
tions (shown as gradients). TCR stimulation with
relatively higher intensities (but below the
threshold required to induce apoptosis) induces
Foxp3 expression, whereas TCR stimulation for an
appropriate length of time produces the Treg-cell-
type DNA hypomethylation pattern. Developing
T cells that happen to have both events (Foxp3+
epigenome+ T cells) are driven to a stable Treg cell
lineage. Foxp3+ T cells without the accompanying
Treg-cell-type epigenome (Foxp3+ epigenome)
are unstable and might lose Foxp3 expression,
whereas T cells with the Treg-cell-type epigenome
but without Foxp3 expression (Foxp3
epigenome+) are ready to express Foxp3 and are
capable of differentiating into functional Treg cells.
T cells that recognize self-ligands too strongly are
negatively selected by apoptosis, whereas those
that recognize self-ligands too weakly fail in posi-
tive selection (death by neglect).
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netic changes but not expressing Foxp3 would easily differen-
tiate into functional Treg cells, whereas Foxp3-expressing
thymocytes without the epigenetic pattern would lose Foxp3
expression and fail to differentiate into Treg cells. Thus, Treg
cell development appears to be multistep processes (with
a stochastic element) involving Foxp3 induction and the estab-
lishment of a Treg-cell-specific epigenetic pattern.
Differences between Thymic Treg and iTreg Cells
Although thymus-derived nTreg cells, in-vitro-generated iTreg
cells, and in-vivo-induced iTreg cells bear similar phenotypes,
such as expression of Foxp3, CD25, and CTLA-4, their epige-
netic status is different. There is a substantial amount of data
indicating that DNA methylation status, especially at the Foxp3
CNS2 locus, is similar between thymic Treg cells and in-vivo-
induced iTreg cells but different between in-vivo-induced iTreg
cells and in-vitro-induced cells (Ohkura et al., 2012; Polansky
et al., 2008). Because DNA demethylation of the Foxp3 CNS2
locus mainly contributes to the stability of Foxp3 expression,
nTreg cells are able to stably maintain Foxp3 expression irre-
spective of extracellular conditions, Foxp3-inducing signals, or
cell proliferation. In contrast, Foxp3+ iTreg cells induced in vitro
by TGF-b and/or retinoic acids are less stable in the expression
of Treg-cell-function-associated molecules, such as Foxp3 and
CTLA-4 (Hill et al., 2007; Ohkura et al., 2012; Polansky et al.,418 Immunity 38, March 21, 2013 ª2013 Elsevier Inc.2010). In vitro TGF-b treatment can
change histone modification status of
the Foxp3 CNS1 region, where several
transcription factors assemble and trans-
activate Foxp3 expression, but fail to
induce Treg-cell-type DNA hypomethyla-
tion in the Foxp3 CNS2 region (Ohkura
et al., 2012; Samstein et al., 2012; Wei
et al., 2009) (Figure 2). In addition, TGF-
b-induced Foxp3 expression is lost after
removal of TGF-b or TCR stimulation in vi-tro (Floess et al., 2007; Selvaraj and Geiger, 2007), suggesting
instability of the expression. A recent report has also shown
that thymus-derived nTreg cells and mucosa-generated iTreg
cells can be distinguished by the expression levels of neuropillin
1 (Nrp1) (Weiss et al., 2012). Similar to Foxp3+Nrp1+ thymic Treg
cells, Foxp3+Nrp1 iTreg cells, which retain DNA demethylation
of the Foxp3 CNS2 region to some extent, are stable and
suppress immune responses in vitro and in vivo. These findings
confirm the importance of Treg-cell-specific DNA demethylation
in cell stability of in-vivo-generated iTreg cells.
In the case of some in-vivo-induced iTreg cells, particularly
those generated in gut-associated lymphoid tissues, Foxp3
expression depends on cytokine milieu, which might lead to
H3K4me3 modification of the CNS1 region. These in-vivo-
induced Foxp3+ T cells gradually acquire DNA demethylation
in the Foxp3 CNS2 region by TCR stimulation (Ohkura et al.,
2012). The differences in developmental processes between
thymus-derived nTreg cells and in vivo iTreg cells are illustrated
by the germ-line deletion of the Foxp3CNS1 region (Zheng et al.,
2010). The CNS1 deletion results in the reduction of iTreg cells,
but not thymic Treg cells, indicating that the CNS1 region, which
acts as a TGF-b sensor through binding of Smad3, is dispens-
able for thymic, but not peripheral, Foxp3 induction.
Thus, Treg-cell-specific epigenetic changes in thymic Treg
cells are primed through the thymic T cell selection process,
whereas the epigenetic alterations in in-vivo-produced iTreg
Figure 4. T Cell Subpopulations Delineated by CD25, Foxp3, and the
Treg-Cell-Type Epigenome
The majority of Foxp3+ T cells are CD25+, and some are CD25. Foxp3+ cells
also contain T cells with or without Treg-cell-type epigenetic changes. Some
T cells with the epigenetic changes are not Foxp3. Thymus-derived nTreg
cells, in-vivo- or in-vitro-produced iTreg cells, and activated or naı¨ve Tconv
cells can be characterized by these molecular markers and events.
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and other unknown stimulations. TGF-b-induced in vitro iTreg
cells do not exhibit such changes.
Treg Cell Identity
The presence of Treg-cell-specific epigenetic changes prompts
one to ask about their relationship with Foxp3 expression—
more specifically, whether T cells possessing the Treg-cell-
specific DNA hypomethylation pattern are identical to those ex-
pressing Foxp3 (Figure 4). Analysis with cell-fate-mapping
reporter mice has demonstrated that a small T cell population
that once expressed Foxp3 and then lost the expression but
held DNA demethylation of the Foxp3 CNS2 region was easily
converted to functional Foxp3+ Treg cells upon TCR stimulation
(Miyao et al., 2012). In contrast, T cells possessing Foxp3
expression but not the Treg-cell-type DNA hypomethylation
pattern fail to exhibit sufficient Treg cell suppressive activity
and instead secrete effector cytokines upon loss of Foxp3
expression (Miyao et al., 2012; Miyara et al., 2009; Ohkura
et al., 2012). In accordance with these findings, Ets-1-deficient
mice, whose Foxp3+ T cells lack Treg-cell-specific DNA deme-
thylation of the Foxp3 CNS2 region, show deficient Treg-cell-
mediated immune suppression and develop autoimmunity
(Mouly et al., 2010). Thus, together with Foxp3 expression, the
Treg-cell-specific DNA hypomethylation pattern can be a reliable
marker for defining functional Treg cells as a distinct cellular
entity.
Interaction between the Transcriptional Network and
the Epigenome
Genome-wide gene expression profiling in Treg cells has de-
picted a variety of transcription factors expressed in Treg cells
and has argued that a certain combination of Foxp3 and other
transcription factors, rather than Foxp3 expression alone, would
be essential for determining Treg cell development and function
(Hill et al., 2007; Samstein et al., 2012). Recently, Fu et al. (2012)
have indicated that any combination of ‘‘quintet’’ transcriptionfactors (e.g., IRF4, Eos, Lef1, Gata1, and Satb1) with Foxp3
can reproduce the Treg-cell-like gene expression profiles in
Tconv cells. It has also been reported that genes directly regu-
lated by Foxp3 are relatively limited (Hill et al., 2007), even though
Foxp3-binding regions are frequently observed in a variety of
loci, especially in promoter regions (Samstein et al., 2012; Zheng
et al., 2007). Furthermore, Foxp3 has been identified as one of
the constituents of large transcriptional complexes, which
contain HDAC, Runx1, and Gata3 (Rudra et al., 2012). These
observations suggest that genome-wide gene expression
profiles of Treg cells are formed by combinations of transcription
factors specifically assembled to compose transcription factor
complexes in Treg cells. The idea might not be inconsistent
with the concept that Treg cell development requires Treg-cell-
specific epigenetic changes but rather complementary in the
establishment of Treg-cell-specific gene expression profiles.
Given the presence of common genes among the genes required
for Treg-cell-type gene expression (Fu et al., 2012), those with
Treg-cell-specific DNaseI-hypersensitive regions (Samstein
et al., 2012), and those with Treg-cell-specific DNA-hypomethy-
lated regions (Ohkura et al., 2012), it is conceivable that Treg-
cell-type epigenetic changes influence the expression levels
and stability of a small number of genes; then, those gene prod-
ucts might control the whole-gene expression pattern in Treg
cells. It is possible that TCR stimulation, along with other extra-
cellular stimulations such as cytokines and metabolic factors,
might activate distinct signaling pathways and thereby deter-
mine the composition of the network of core transcription
factors.
Treg Cell Plasticity and Adaptability
The plasticity or stability of Treg cells is controversial—in partic-
ular, regarding whether Foxp3-expressing nTreg cells, which are
apparently more self-reactive than Tconv cells in their TCR
repertoire, might differentiate into hazardous autoimmune
effector T cells (Bailey-Bucktrout and Bluestone, 2011; Hori,
2011). For example, some Treg cells lose Foxp3 expression
and differentiate into effector T cells (Komatsu et al., 2009; Xu
et al., 2007; Yang et al., 2008; Zhou et al., 2009b). In addition,
exposure to Th1- or Th17-cell-polarizing stimuli for a prolonged
period modulates Treg cells to produce inflammatory cytokines
and to lose suppressive activity (Xu et al., 2007; Zhao et al.,
2011). However, findings with cell-fate-mapping reporter mice
argue that ‘‘the plasticity’’ of Treg cells could be attributed to
the presence of a minor population of Foxp3+ T cells that lack
Foxp3 CNS2 demethylation (Miyao et al., 2012). Functional and
phenotypic heterogeneity of FOXP3+ cells is more evident in hu-
mans in that they include FOXP3hi cells with potent suppressive
activity and FOXP3lo nonsuppressive cells capable of secreting
proinflammatory cytokines (Miyara et al., 2009). Suppressive
activities of these populations are well correlated with their
DNA methylation status of the FOXP3 CNS2 region.
Although Treg-cell-specific epigenetic changes are critical for
Treg cell stability, extrinsic signals are also important for control-
ling Foxp3 expression and thus for maintaining Treg cells. For
example, hypoxia-inducible factor 1 (HIF-1), a key metabolic
sensor, regulates the balance between Treg and Th17 cell differ-
entiation (Dang et al., 2011). HIF-1 is selectively expressed in
Th17 cells, and its induction requires signaling through mTOR,Immunity 38, March 21, 2013 ª2013 Elsevier Inc. 419
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attenuates Treg cell development through an active process that
targets Foxp3 for degradation. These findings indicate that
metabolic-signal-dependent transcriptional regulation would
be important for the lineage choices between Th17 and Treg
cells. Complement fragments also affect the balance between
Th17 and Treg cells. Signaling through the G-protein-coupled
receptors for the complement fragments C3a and C5a in
dendritic cells and CD4+ cells enhances Th17 cell induction
(Strainic et al., 2013). Conversely, when signals from C3aR and
C5aR are inhibited in CD4+ T cells, signal reduction in the
PI3K-Akt-mTOR pathway and an increase in autocrine TGF-b
signaling enhance Foxp3+ iTreg cell generation. Moreover,
Foxo transcription factors, which integrate extrinsic signals to
regulate cell division, differentiation, and survival, have a pivotal
role in the development of both thymic and induced Treg cells
(Kerdiles et al., 2009; Kerdiles et al., 2010; Ouyang et al., 2010;
Ouyang et al., 2012). Thus, extracellular stimulation would also
be important for the stability and plasticity of Foxp3+ Treg cells.
It is, however, largely obscure whether these extrinsic stimula-
tions can alter the Treg-cell-specific epigenetic pattern, given
that Foxp3 expression and the establishment of the Treg-cell-
type epigenetic pattern are independent events in the course
of Treg cell development (Ohkura et al., 2012).
Recent work has demonstrated that Treg cells are able to
adapt to environmental signals and further differentiate by ex-
pressing transcription factors normally associated with Th cell
subsets (Campbell and Koch, 2011). The development of
T-bet+ Treg cells occurs in response to IFN-g produced by
effector T cells. T-bet induces the Th1-cell-associated chemo-
kine receptor CXCR3, which enables the T-bet+ Treg cells to
migrate to a type 1 inflammation site and suppress local Th1
immune responses (Hall et al., 2012; Koch et al., 2009). T-bet-
deficient Treg cells are indeed unable to accumulate at the site
of Th1 inflammation and properly control the Th1 immune
response. Additionally, IRF4+ Treg cells control type 2 inflamma-
tion. Treg-cell-specific deletion of Irf4 prevents Treg cells from
efficiently suppressing Th2 immune responses, leading to
uncontrolled Th2 immune responses (Zheng et al., 2009). Thus,
it is likely that Treg and Tconv cells can respond to common
differentiation stimuli and acquire some common phenotypes
and function (e.g., migratory capacity to the same inflammation
site). However, there is also a difference between the two popu-
lations in transcriptional regulation. For example, in Tconv cells,
STAT1 activation by IFN-g induces the expression of T-bet,
which in turn drives expression of the IL-12 receptor component
IL-12Rb2 (Afkarian et al., 2002; Mullen et al., 2001). This allows
the cells to undergo IL-12-dependent activation of Ifng and other
genes required for proper function of Th1 cells. Koch et al. (Koch
et al., 2009) revealed that in Treg cells, delayed induction of IL-
12Rb2 after STAT1 activation helps ensure that Treg cells do
not readily complete Th1 cell differentiation and lose their
suppressive ability. In that study, deletion of Foxp3 in Treg cells
failed to upregulate IL12Rb2 expression, indicating that the
repression of IL-12Rb2 expression is mediated by a Foxp3-inde-
pendent mechanism in Treg cells. Because Treg-cell-specific
epigenetic changes contribute to Treg-cell-specific gene
expression and occur in a small number of loci (Ohkura et al.,
2012), the changes might allow Tconv-like behavior in Treg cells420 Immunity 38, March 21, 2013 ª2013 Elsevier Inc.while keeping the expression of some core factors critical for
Treg cell function.
As discussed above, the molecular and cellular basis of Treg
cell stability and plasticity, as well as heterogeneity, remains
a key issue of Treg cell research. For clinical use of functionally
stable Treg cells for immunosuppression, it is necessary to
know more precisely the developmental processes of Treg cells
in terms of Foxp3 expression and epigenetic changes and deter-
mine the conditions under which these two events become
discrepant and affect the functional stability of Treg cells.
Furthermore, elucidation of the mechanisms underlying the
induction of Treg-cell-specific epigenetic changesmight provide
new opportunities for pharmacological intervention.
Does Epigenetic Priming Occur in Other T Cell Subsets?
Similar to the case with Treg cells, epigenetics features of other
T cell subsets have been investigated. After the differentiation of
naı¨veCD4+ T cells into helper T cells, newDNaseI-hypersensitive
regions and specific DNA demethylation are observed at the Ifng
or Il4 locus in Th1 or Th2 cells, respectively, and de novo meth-
ylation takes place at the Il4 or Ifng locus in Th1 or Th2 cells,
respectively, to repress unwanted gene transcription (Ansel
et al., 2003; Thomas et al., 2012). However, such clear-cut recip-
rocal epigenetic regulation is not seen between Th1 and Th17
cells; the distribution pattern of DNaseI-hypersensitive sites
within the Ifng locus is similar between activated Th17 and Th1
cells, consistent with the ability of Th17 cells to produce IFN-g
under Th1-cell-polarizing conditions (Hirota et al., 2011; Mukasa
et al., 2010). In addition, Th9, Th22, and Tfh cells were recently
reported as distinct subsets of CD4+ T cells given their unique
expression of cytokines or transcription factors (Annunziato
and Romagnani, 2009; Fazilleau et al., 2009). Thus, it remains
to be determined how the epigenetic status of these various Th
cell subpopulations contributes to their lineage stability and
plasticity in cytokine production.
Conclusions and Perspectives
As discussed in this review, Foxp3 induction and the establish-
ment of the Treg-cell-type epigenetic pattern are independent
but complementary events in the course of Treg cell develop-
ment. Furthermore, Treg-cell-specific epigenetic changes,
especially DNA hypomethylation, make a cell poised for ex-
pressing not only Foxp3 but also other Treg-cell-function-asso-
ciated molecules and contribute to the stability of cell lineages
that are critical for long-term immune tolerance. Treg-cell-type
epigenetic change is therefore a key molecular event for defining
Treg cells as a functionally distinct T cell subpopulation. It is also
vital for preparing functionally stable Foxp3+ Treg cells for clinical
use. It has been shown that Foxp3 can be induced in Tconv cells
by a variety of molecules, such as TGF-b, retinoic acids, rapamy-
cin, and sphingosine 1-phosphate receptor agonist FTY720
(Battaglia et al., 2006; Hill et al., 2008; Mucida et al., 2007;
Zhou et al., 2009a), and that several signaling pathways,
including those of NFAT, Smad3, and the Nr4a family, are critical
for inducing Foxp3 expression (Sekiya et al., 2011; Sekiya et al.,
2013; Tone et al., 2008; Xu et al., 2010). Regarding Treg-cell-type
epigenetics, it remains to be determined how locus-specific DNA
demethylation occurs in the course of Treg cell development and
what types of extracellular stimulations can install Treg-cell-type
Immunity
Reviewepigenetic changes. In addition, elucidating the crosstalk
between different epigenetic modifications, including chromatin
remodeling, histone modifications, and DNA methylation, and
their respective roles in epigenetic regulation is essential for
our understanding of the contribution of Treg-cell-type epige-
netic changes to Treg cell development and function. This will
enable better control of immune responses in clinical settings
via targeting the generation and maintenance of thymus-derived
and peripherally induced Treg cells.
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